We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

HIV/AIDS 2010 Better Drugs, Better Technologies, and Lingering Problems

Mitchell H. Katz, MD
Arch Intern Med. 2010;170(1):6-8. doi:10.1001/archinternmed.2009.442.
Text Size: A A A
Published online


Progress in the treatment of human immunodeficiency virus (HIV) and AIDS has been breathtaking. In the early 1980s, a diagnosis of AIDS was thought to be synonymous with death. Today, with available antiretroviral therapies, the life expectancy of HIV-infected persons nears that of age-matched uninfected persons.1

Bhaskaran  KHamouda  OSannes  M  et al. CASCADE Collaboration, Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA 2008;300 (1) 51- 59
PubMed Link to Article[[XSLOpenURL/10.1001/jama.300.1.51]]
Fischl  MARichman  DDGrieco  MH  et al.  The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987;317 (4) 185- 191
PubMed Link to Article[[XSLOpenURL/10.1056/NEJM198707233170401]]
Volberding  PALagakos  SWKoch  MA  et al. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases, Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990;322 (14) 941- 949
PubMed Link to Article[[XSLOpenURL/10.1056/NEJM199004053221401]]
Hamilton  JDHartigan  PMSimberkoff  MS  et al.  A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection: results of the Veterans Affairs Cooperative Study. N Engl J Med 1993;326437- 443
PubMed Link to Article[[XSLOpenURL/10.1056/NEJM199202133260703]]
Lundgren  JDPhillips  ANPedersen  C  et al.  Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine: AIDS in Europe Study Group. JAMA 1994;271 (14) 1088- 1092
PubMed Link to Article[[XSLOpenURL/10.1001/jama.1994.03510380044035]]
Moore  RDKeruly  JCChaisson  RE Duration of the survival benefit of zidovudine therapy in HIV infection. Arch Intern Med 1996;156 (10) 1073- 1077
PubMed Link to Article[[XSLOpenURL/10.1001/archinte.1996.00040041073005]]
Palella  FJ  JrDelaney  KMMoorman  AC  et al. HIV Outpatient Study Investigators, Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338 (13) 853- 860
PubMed Link to Article[[XSLOpenURL/10.1056/NEJM199803263381301]]
Elzi  LMarzolini  CFurrer  H  et al. the Swiss HIV Cohort Study, Treatment modification in human immunodeficiency virus–infected individuals starting combination antiretroviral therapy between 2005 and 2008. Arch Intern Med 2010;170 (1) 57- 65
Link to Article[[XSLOpenURL/10.1001/archinternmed.2009.432]]
Richman  DDMorton  SCWrin  T  et al.  The prevalence of antiretroviral drug resistance in the United States. AIDS 2004;18 (10) 1393- 1401
PubMed Link to Article[[XSLOpenURL/10.1097/01.aids.0000131310.52526.c7]]
McNicholl  IR Strategies to enhance adherence, reduce costs, and improve patient quality of life. J Manag Care Pharm 2008;14(suppl a)S12- S16
Zaric  GSBayoumi  AMBrandeau  MLOwens  DK The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men. Med Decis Making 2008;28 (3) 359- 376
PubMed Link to Article[[XSLOpenURL/10.1177/0272989X07312714]]
Golin  CESmith  SRReif  S Adherence counseling practices of generalist and specialist physicians caring for people living with HIV/AIDS in North Carolina. J Gen Intern Med 2004;19 (1) 16- 27
PubMed Link to Article[[XSLOpenURL/10.1111/j.1525-1497.2004.21151.x]]
Branson  BMHandsfield  HHLampe  MA  et al.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006;55 (RR-14) 1- 17
Marks  GCrepaz  NSenterfitt  JWJanssen  RS Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005;39 (4) 446- 453
PubMed Link to Article[[XSLOpenURL/10.1097/01.qai.0000151079.33935.79]]
Zetola  NMGrijalva  CGGertler  S  et al.  Simplifying consent for HIV testing is associated with an increase in HIV testing and case detection in highest risk groups, San Francisco January 2003-June 2007. PLoS One 2008;3 (7) e2591
PubMed Link to Article[[XSLOpenURL/10.1371/journal.pone.0002591]]
Greenwald  JLBurstein  GRPincus  JBranson  B A rapid review of rapid HIV antibody tests. Curr Infect Dis Rep 2006;8 (2) 125- 131
PubMed Link to Article[[XSLOpenURL/10.1007/s11908-006-0008-6]]
Patel  PMackellar  DSimmons  P  et al. Centers for Disease Control and Prevention Acute HIV Infection Study Group, Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med 2010;170 (1) 66- 74
PubMed Link to Article[[XSLOpenURL/10.1001/archinternmed.2009.445]]
Centers for Disease Control and Prevention (CDC), Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm Rep 2008;57 (RR-9) 1- 83
 Estimates of new HIV infection in the United States: CDC HIV/AIDS facts: August 2008. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/hiv/topics/surveillance/resources/factsheets/incidence.htm. Accessed October 21, 2009
 2008 Report on the global AIDS epidemic: executive summary. UNAIDS Web site. http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008_Global_report.asp. Accessed October 21, 2009
Centers for Disease Control and Prevention (CDC), Achievements in public health: reduction in perinatal transmission of HIV infection—United States, 1985-2005. MMWR Morb Mortal Wkly Rep 2006;55 (21) 592- 597
Lyles  CMKay  LSCrepaz  N  et al. HIV/AIDS Prevention Research Synthesis Team, Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US population at high risk, 2000-2004. Am J Public Health 2007;97 (1) 133- 143
PubMed Link to Article[[XSLOpenURL/10.2105/AJPH.2005.076182]]
Noar  SM Behavioral interventions to reduce HIV-related sexual risk behavior: review and synthesis of meta-analytic evidence. AIDS Behav 2008;12 (3) 335- 353
PubMed Link to Article[[XSLOpenURL/10.1007/s10461-007-9313-9]]
Buchbinder  S The epidemiology of new HIV infections and interventions to limit HIV transmission. Top HIV Med 2009;17 (2) 37- 43
D’Cruz  OJUckun  FM Clinical development of microbicides for the prevention of HIV infection. Curr Pharm Des 2004;10 (3) 315- 336
PubMed Link to Article[[XSLOpenURL/10.2174/1381612043386374]]
Stover  K In Thailand clinical study, HIV vaccine regimen demonstrates modest preventive effect. Medical News Today Web site. http://www.medicalnewstoday.com/articles/165277.php. Accessed September 25, 2009



Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

2 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Care at the Close of Life: Evidence and Experience
Overcoming the False Dichotomy of Curative vs Palliative Care for Late-Stage HIV/AIDS: "Let Me Live the Way I Want to Live, Until I Can't"

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Evidence to Support the Update